• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4640408)   Today's Articles (208)   Subscriber (50364)
For: Ankerst DP, Hoefler J, Bock S, Goodman PJ, Vickers A, Hernandez J, Sokoll LJ, Sanda MG, Wei JT, Leach RJ, Thompson IM. Prostate Cancer Prevention Trial risk calculator 2.0 for the prediction of low- vs high-grade prostate cancer. Urology 2014;83:1362-7. [PMID: 24862395 DOI: 10.1016/j.urology.2014.02.035] [Citation(s) in RCA: 166] [Impact Index Per Article: 16.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/05/2013] [Revised: 02/07/2014] [Accepted: 02/07/2014] [Indexed: 11/26/2022]
Number Cited by Other Article(s)
1
Schmit S, Malshy K, Ochsner A, Golijanin B, Tucci C, Braunagel T, Golijanin D, Pareek G, Hyams E. Lower urinary tract symptoms in elderly men: Considerations for prostate cancer testing. Prostate 2024;84:1290-1300. [PMID: 39051612 DOI: 10.1002/pros.24772] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/29/2024] [Revised: 06/24/2024] [Accepted: 07/15/2024] [Indexed: 07/27/2024]
2
Leni R, Vertosick EA, van den Bergh RC, Soeterik TF, Heetman JG, van Melick HH, Roscigno M, La Croce G, Da Pozzo LF, Olivier J, Zattoni F, Facco M, Dal Moro F, Chiu PK, Wu X, Heidegger I, Giannini G, Bianchi L, Lampariello L, Quarta L, Salonia A, Montorsi F, Briganti A, Capitanio U, Carlsson SV, Vickers AJ, Gandaglia G. Oncologic Outcomes of Incidental Versus Biopsy-diagnosed Grade Group 1 Prostate Cancer: A Multi-institutional Study. EUR UROL SUPPL 2024;68:10-17. [PMID: 39257622 PMCID: PMC11382210 DOI: 10.1016/j.euros.2024.08.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 08/05/2024] [Indexed: 09/12/2024]  Open
3
Palmisano F, Lorusso V, Legnani R, Martorello V, Nedbal C, Tramanzoli P, Marchesotti F, Ferraro S, Talso M, Granata AM, Sighinolfi MC, Rocco B, Gregori A. Analysis of the Performance and Accuracy of a PSA and PSA Ratio-Based Nomogram to Predict the Probability of Prostate Cancer in a Cohort of Patients with PIRADS 3 Findings at Multiparametric Magnetic Resonance Imaging. Cancers (Basel) 2024;16:3084. [PMID: 39272942 PMCID: PMC11394649 DOI: 10.3390/cancers16173084] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/06/2024] [Revised: 08/29/2024] [Accepted: 09/03/2024] [Indexed: 09/15/2024]  Open
4
Lacson R, Haj-Mirzaian A, Burk K, Glazer DI, Naik S, Khorasani R, Kibel AS. A Model for Predicting Clinically Significant Prostate Cancer Using Prostate MRI and Risk Factors. J Am Coll Radiol 2024;21:1419-1427. [PMID: 38719106 DOI: 10.1016/j.jacr.2024.02.035] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/04/2024] [Revised: 02/16/2024] [Accepted: 02/22/2024] [Indexed: 06/10/2024]
5
Şahin B, Çetin S, Sözen S, Aslan G, Çelik S, Türkeri L. A novel nomogram to predict clinically significant prostate cancer in MR assisted lesion biopsies: Turkish urooncology association nomogram. Urol Oncol 2024;42:288.e17-288.e25. [PMID: 38782675 DOI: 10.1016/j.urolonc.2024.04.015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/07/2024] [Revised: 04/10/2024] [Accepted: 04/14/2024] [Indexed: 05/25/2024]
6
Jiang S, Lu F, Chen J, Jiao Y, Qiu Q, Nian X, Qu M, Wang Y, Li M, Liu F, Gao X. UPCARE: Urinary Extracellular Vesicles-Derived Prostate Cancer Assessment for Risk Evaluation. J Extracell Vesicles 2024;13:e12491. [PMID: 39175282 PMCID: PMC11341834 DOI: 10.1002/jev2.12491] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/25/2024] [Revised: 06/12/2024] [Accepted: 07/01/2024] [Indexed: 08/24/2024]  Open
7
van Harten MJ, Roobol MJ, van Leeuwen PJ, Willemse PPM, van den Bergh RCN. Evolution of European prostate cancer screening protocols and summary of ongoing trials. BJU Int 2024;134:31-42. [PMID: 38469728 DOI: 10.1111/bju.16311] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/13/2024]
8
Hyndman ME, Paproski RJ, Kinnaird A, Fairey A, Marks L, Pavlovich CP, Fletcher SA, Zachoval R, Adamcova V, Stejskal J, Aprikian A, Wallis CJD, Pink D, Vasquez C, Beatty PH, Lewis JD. Development of an effective predictive screening tool for prostate cancer using the ClarityDX machine learning platform. NPJ Digit Med 2024;7:163. [PMID: 38902526 PMCID: PMC11190196 DOI: 10.1038/s41746-024-01167-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/08/2024] [Accepted: 06/12/2024] [Indexed: 06/22/2024]  Open
9
Denijs FB, van Harten MJ, Meenderink JJL, Leenen RCA, Remmers S, Venderbos LDF, van den Bergh RCN, Beyer K, Roobol MJ. Risk calculators for the detection of prostate cancer: a systematic review. Prostate Cancer Prostatic Dis 2024:10.1038/s41391-024-00852-w. [PMID: 38830997 DOI: 10.1038/s41391-024-00852-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/27/2024] [Revised: 05/17/2024] [Accepted: 05/23/2024] [Indexed: 06/05/2024]
10
Lee KM, Nelson TJ, Bryant A, Teerlink CC, Gulati R, Pagadala MS, Tcheandjieu C, Pridgen KM, DuVall SL, Yamoah K, Vassy JL, Seibert TM, Hauger RL, Rose BS, Lynch JA. Genetic risk and likelihood of prostate cancer detection on first biopsy by ancestry. J Natl Cancer Inst 2024;116:753-757. [PMID: 38212986 PMCID: PMC11077300 DOI: 10.1093/jnci/djae002] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/10/2023] [Revised: 11/03/2023] [Accepted: 12/23/2023] [Indexed: 01/13/2024]  Open
11
Orbe Villota PM, Leiva Centeno JA, Lugones J, Minuzzi PG, Varea SM. Comparison between the European Randomized Study for Screening of Prostate Cancer (ERSPC) and Prostate Biopsy Collaborative Group (PBCG) risk calculators: Prediction of clinically significant Prostate Cancer risk in a cohort of patients from Argentina. Actas Urol Esp 2024;48:210-217. [PMID: 37827241 DOI: 10.1016/j.acuroe.2023.10.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/18/2023] [Revised: 07/24/2023] [Accepted: 07/25/2023] [Indexed: 10/14/2023]
12
Fiedorowicz JG, Merranko JA, Goldstein TR, Hower H, Iyengar S, Hafeman DM, Hunt JI, Strober M, Keller MB, Goldstein BI, Diler RS, Siddiqi S, Birmaher B. Validation of a youth suicide risk calculator in an adult sample with bipolar disorder. J Affect Disord 2024;347:278-284. [PMID: 38007103 PMCID: PMC11022308 DOI: 10.1016/j.jad.2023.11.066] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/09/2023] [Revised: 11/08/2023] [Accepted: 11/18/2023] [Indexed: 11/27/2023]
13
Vickers AJ, Lilja H. Eight Misconceptions about Prostate-Specific Antigen. Clin Chem 2024;70:13-16. [PMID: 38175588 DOI: 10.1093/clinchem/hvad138] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/31/2023] [Accepted: 07/03/2023] [Indexed: 01/05/2024]
14
Bhasin S, Travison TG, Pencina KM, O’Leary M, Cunningham GR, Lincoff AM, Nissen SE, Lucia MS, Preston MA, Khera M, Khan N, Snabes MC, Li X, Tangen CM, Buhr KA, Thompson IM. Prostate Safety Events During Testosterone Replacement Therapy in Men With Hypogonadism: A Randomized Clinical Trial. JAMA Netw Open 2023;6:e2348692. [PMID: 38150256 PMCID: PMC10753401 DOI: 10.1001/jamanetworkopen.2023.48692] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/01/2023] [Accepted: 11/06/2023] [Indexed: 12/28/2023]  Open
15
Tao W, Wang BY, Luo L, Li Q, Meng ZA, Xia TL, Deng WM, Yang M, Zhou J, Zhang X, Gao X, Li LY, He YD. A urine extracellular vesicle lncRNA classifier for high-grade prostate cancer and increased risk of progression: A multi-center study. Cell Rep Med 2023;4:101240. [PMID: 37852185 PMCID: PMC10591064 DOI: 10.1016/j.xcrm.2023.101240] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/07/2023] [Revised: 07/03/2023] [Accepted: 09/21/2023] [Indexed: 10/20/2023]
16
Presti J, Alexeeff S, Avins AL. Screening for Prostate Cancer. N Engl J Med 2023;389:93-94. [PMID: 37407016 DOI: 10.1056/nejmc2305651] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 07/07/2023]
17
Ferro M, Rocco B, Maggi M, Lucarelli G, Falagario UG, Del Giudice F, Crocetto F, Barone B, La Civita E, Lasorsa F, Brescia A, Catellani M, Busetto GM, Tataru OS, Terracciano D. Beyond blood biomarkers: the role of SelectMDX in clinically significant prostate cancer identification. Expert Rev Mol Diagn 2023;23:1061-1070. [PMID: 37897252 DOI: 10.1080/14737159.2023.2277366] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/06/2023] [Accepted: 10/26/2023] [Indexed: 10/30/2023]
18
Han P, Taylor JM, Mukherjee B. Integrating Information from Existing Risk Prediction Models with No Model Details. CAN J STAT 2023;51:355-374. [PMID: 37346757 PMCID: PMC10281716 DOI: 10.1002/cjs.11701] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/14/2020] [Accepted: 12/16/2021] [Indexed: 11/07/2022]
19
Patel HD, Koehne EL, Shea SM, Fang AM, Gerena M, Gorbonos A, Quek ML, Flanigan RC, Goldberg A, Rais‐Bahrami S, Gupta GN. A prostate biopsy risk calculator based on MRI: development and comparison of the Prospective Loyola University multiparametric MRI (PLUM) and Prostate Biopsy Collaborative Group (PBCG) risk calculators. BJU Int 2023;131:227-235. [PMID: 35733400 PMCID: PMC9772358 DOI: 10.1111/bju.15835] [Citation(s) in RCA: 5] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
20
Harper JB, Greenberg SE, Hunt TC, Cooney KA, O’Neil BB. Initial outcomes and insights from a novel high-risk prostate cancer screening clinic. Prostate 2023;83:151-157. [PMID: 36207779 PMCID: PMC9772159 DOI: 10.1002/pros.24447] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/31/2022] [Accepted: 09/21/2022] [Indexed: 02/05/2023]
21
Wang C, Yuan L, Shen D, Zhang B, Wu B, Zhang P, Xiao J, Tao T. Combination of PI-RADS score and PSAD can improve the diagnostic accuracy of prostate cancer and reduce unnecessary prostate biopsies. Front Oncol 2022;12:1024204. [PMID: 36465344 PMCID: PMC9709422 DOI: 10.3389/fonc.2022.1024204] [Citation(s) in RCA: 7] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/21/2022] [Accepted: 10/20/2022] [Indexed: 09/27/2023]  Open
22
Pfeiffer RM, Chen Y, Gail MH, Ankerst DP. Accommodating population differences when validating risk prediction models. Stat Med 2022;41:4756-4780. [PMID: 36224712 PMCID: PMC10510530 DOI: 10.1002/sim.9447] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/03/2021] [Revised: 01/19/2022] [Accepted: 05/11/2022] [Indexed: 11/11/2022]
23
Van Poppel H, Albreht T, Basu P, Hogenhout R, Collen S, Roobol M. Serum PSA-based early detection of prostate cancer in Europe and globally: past, present and future. Nat Rev Urol 2022;19:562-572. [PMID: 35974245 DOI: 10.1038/s41585-022-00638-6] [Citation(s) in RCA: 62] [Impact Index Per Article: 31.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 07/14/2022] [Indexed: 12/14/2022]
24
Neumair M, Kattan MW, Freedland SJ, Haese A, Guerrios-Rivera L, De Hoedt AM, Liss MA, Leach RJ, Boorjian SA, Cooperberg MR, Poyet C, Saba K, Herkommer K, Meissner VH, Vickers AJ, Ankerst DP. Accommodating heterogeneous missing data patterns for prostate cancer risk prediction. BMC Med Res Methodol 2022;22:200. [PMID: 35864460 PMCID: PMC9306143 DOI: 10.1186/s12874-022-01674-x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/03/2021] [Accepted: 07/04/2022] [Indexed: 12/30/2022]  Open
25
Wang G, Choi KS, Teoh JYC, Lu J. Deep Cross-Output Knowledge Transfer Using Stacked-Structure Least-Squares Support Vector Machines. IEEE TRANSACTIONS ON CYBERNETICS 2022;52:3207-3220. [PMID: 32780705 DOI: 10.1109/tcyb.2020.3008963] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/11/2023]
26
Mason RJ, Marzouk K, Finelli A, Saad F, So AI, Violette PD, Breau RH, Rendon RA. UPDATE - 2022 Canadian Urological Association recommendations on prostate cancer screening and early diagnosis Endorsement of the 2021 Cancer Care Ontario guidelines on prostate multiparametric magnetic resonance imaging. Can Urol Assoc J 2022;16:E184-E196. [PMID: 35358414 PMCID: PMC9054332 DOI: 10.5489/cuaj.7851] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
27
Hayes FJ. Monitoring of Testosterone Replacement Therapy to Optimize the Benefit-to-Risk Ratio. Endocrinol Metab Clin North Am 2022;51:99-108. [PMID: 35216723 DOI: 10.1016/j.ecl.2021.11.013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
28
Kinnaird A, Brisbane W, Kwan L, Priester A, Chuang R, Barsa DE, Delfin M, Sisk A, Margolis D, Felker E, Hu J, Marks LS. A prostate cancer risk calculator: Use of clinical and magnetic resonance imaging data to predict biopsy outcome in North American men. Can Urol Assoc J 2022;16:E161-E166. [PMID: 34672937 PMCID: PMC8923894 DOI: 10.5489/cuaj.7380] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
29
Jethwani DL, Sivamoorthy LL, Toh CC, Malek R. Predicting the diagnosis of prostate cancer with a scoring system based on novel biomarkers. BMC Urol 2022;22:13. [PMID: 35109827 PMCID: PMC8808971 DOI: 10.1186/s12894-022-00956-2] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/30/2021] [Accepted: 01/12/2022] [Indexed: 01/04/2023]  Open
30
Fang AM, Rais-Bahrami S. Magnetic resonance imaging-based risk calculators optimize selection for prostate biopsy among biopsy-naive men. Cancer 2022;128:25-27. [PMID: 34427940 DOI: 10.1002/cncr.33872] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2021] [Accepted: 08/05/2021] [Indexed: 11/08/2022]
31
Personalized 5-Year Prostate Cancer Risk Prediction Model in Korea Based on Nationwide Representative Data. J Pers Med 2021;12:jpm12010002. [PMID: 35055319 PMCID: PMC8780119 DOI: 10.3390/jpm12010002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/03/2021] [Revised: 12/09/2021] [Accepted: 12/16/2021] [Indexed: 11/16/2022]  Open
32
Fiedorowicz JG, Merranko JA, Iyengar S, Hower H, Gill MK, Yen S, Goldstein TR, Strober M, Hafeman D, Keller MB, Goldstein BI, Diler RS, Hunt JI, Birmaher BB. Validation of the youth mood recurrences risk calculator in an adult sample with bipolar disorder. J Affect Disord 2021;295:1482-1488. [PMID: 34563392 DOI: 10.1016/j.jad.2021.09.037] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/04/2021] [Revised: 08/12/2021] [Accepted: 09/12/2021] [Indexed: 10/20/2022]
33
Yıldızhan M, Balcı M, Eroğlu U, Asil E, Coser S, Özercan AY, Köseoğlu B, Güzel O, Asfuroğlu A, Tuncel A. An analysis of three different prostate cancer risk calculators applied prior to prostate biopsy: A Turkish cohort validation study. Andrologia 2021;54:e14329. [PMID: 34837424 DOI: 10.1111/and.14329] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/21/2021] [Revised: 11/13/2021] [Accepted: 11/14/2021] [Indexed: 10/19/2022]  Open
34
Chang EK, Gadzinski AJ, Nyame YA. Blood and urine biomarkers in prostate cancer: Are we ready for reflex testing in men with an elevated prostate-specific antigen? Asian J Urol 2021;8:343-353. [PMID: 34765442 PMCID: PMC8566358 DOI: 10.1016/j.ajur.2021.06.003] [Citation(s) in RCA: 13] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/14/2021] [Revised: 05/17/2021] [Accepted: 05/26/2021] [Indexed: 10/28/2022]  Open
35
Sheikh MT, Chen MH, Gelfond JA, Ibrahim JG. A Power Prior Approach for Leveraging External Longitudinal and Competing Risks Survival Data Within the Joint Modeling Framework. STATISTICS IN BIOSCIENCES 2021. [DOI: 10.1007/s12561-021-09330-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
36
Eyrich NW, Wei JT, Niknafs YS, Siddiqui J, Ellimoottil C, Salami SS, Palapattu GS, Mehra R, Kunju LP, Tomlins SA, Chinnaiyan AM, Morgan TM, Tosoian JJ. Association of MyProstateScore (MPS) with prostate cancer grade in the radical prostatectomy specimen. Urol Oncol 2021;40:4.e1-4.e7. [PMID: 34753659 DOI: 10.1016/j.urolonc.2021.09.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/23/2021] [Revised: 09/02/2021] [Accepted: 09/19/2021] [Indexed: 11/28/2022]
37
Setia S, Jackson J, Cendo D, Gorin MA, Allaway M, Vourganti S. Assessing the diagnostic performance of systematic freehand PrecisionPoint transperineal prostate biopsy: Comparison of observed outcomes to PBCG nomogram predictions. Urol Oncol 2021;40:4.e9-4.e17. [PMID: 34688533 DOI: 10.1016/j.urolonc.2021.08.029] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/09/2021] [Revised: 08/08/2021] [Accepted: 08/30/2021] [Indexed: 11/30/2022]
38
Ghosh D, Sabel MS. A Weighted Sample Framework to Incorporate External Calculators for Risk Modeling. STATISTICS IN BIOSCIENCES 2021. [DOI: 10.1007/s12561-021-09325-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
39
Stojadinovic M, Milicevic B, Jankovic S. Improved predictive performance of prostate biopsy collaborative group risk calculator when based on automated machine learning. Comput Biol Med 2021;138:104903. [PMID: 34598066 DOI: 10.1016/j.compbiomed.2021.104903] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/27/2021] [Revised: 09/05/2021] [Accepted: 09/23/2021] [Indexed: 01/29/2023]
40
Margolis E, Brown G, Partin A, Carter B, McKiernan J, Tutrone R, Torkler P, Fischer C, Tadigotla V, Noerholm M, Donovan MJ, Skog J. Predicting high-grade prostate cancer at initial biopsy: clinical performance of the ExoDx (EPI) Prostate Intelliscore test in three independent prospective studies. Prostate Cancer Prostatic Dis 2021;25:296-301. [PMID: 34593984 PMCID: PMC9184274 DOI: 10.1038/s41391-021-00456-8] [Citation(s) in RCA: 35] [Impact Index Per Article: 11.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/19/2021] [Revised: 08/21/2021] [Accepted: 09/09/2021] [Indexed: 12/24/2022]
41
Bandala-Jacques A, Castellanos Esquivel KD, Pérez-Hurtado F, Hernández-Silva C, Reynoso-Noverón N. Prostate Cancer Risk Calculators for Healthy Populations: Systematic Review. JMIR Cancer 2021;7:e30430. [PMID: 34477564 PMCID: PMC8449298 DOI: 10.2196/30430] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/13/2021] [Revised: 07/12/2021] [Accepted: 07/28/2021] [Indexed: 11/15/2022]  Open
42
Xu B, Li G, Kong C, Chen M, Hu B, Jiang Q, Li N, Zhou L. A multicenter retrospective study on evaluation of predicative factors for positive biopsy of prostate cancer in real-world setting. Curr Med Res Opin 2021;37:1617-1625. [PMID: 34192993 DOI: 10.1080/03007995.2021.1949270] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/06/2023]
43
Van Poppel H, Hogenhout R, Albers P, van den Bergh RCN, Barentsz JO, Roobol MJ. A European Model for an Organised Risk-stratified Early Detection Programme for Prostate Cancer. Eur Urol Oncol 2021;4:731-739. [PMID: 34364829 DOI: 10.1016/j.euo.2021.06.006] [Citation(s) in RCA: 51] [Impact Index Per Article: 17.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/31/2021] [Revised: 06/10/2021] [Accepted: 06/23/2021] [Indexed: 11/16/2022]
44
A 25-year perspective on evaluation and understanding of biomarkers in urologic cancers. Urol Oncol 2021;39:602-617. [PMID: 34315659 DOI: 10.1016/j.urolonc.2021.06.010] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2021] [Accepted: 06/17/2021] [Indexed: 12/15/2022]
45
He YD, Tao W, He T, Wang BY, Tang XM, Zhang LM, Wu ZQ, Deng WM, Zhang LX, Shao CK, Zhou J, Rong LM, Gao X, Li LY. A urine extracellular vesicle circRNA classifier for detection of high-grade prostate cancer in patients with prostate-specific antigen 2-10 ng/mL at initial biopsy. Mol Cancer 2021;20:96. [PMID: 34301266 PMCID: PMC8299620 DOI: 10.1186/s12943-021-01388-6] [Citation(s) in RCA: 38] [Impact Index Per Article: 12.7] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/07/2021] [Accepted: 06/25/2021] [Indexed: 02/07/2023]  Open
46
Patel HD, Doshi CP, Koehne EL, Hart S, Van Kuiken M, Quek ML, Flanigan RC, Gupta GN. African American Men have Increased Risk of Prostate Cancer Detection Despite Similar Rates of Anterior Prostatic Lesions and PI-RADS Grade on Multiparametric Magnetic Resonance Imaging. Urology 2021;163:132-137. [PMID: 34302832 DOI: 10.1016/j.urology.2021.07.005] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2021] [Revised: 06/21/2021] [Accepted: 07/08/2021] [Indexed: 01/17/2023]
47
Amaya-Fragoso E, García-Pérez CM. Improving prostate biopsy decision making in Mexican patients: Still a major public health concern. Urol Oncol 2021;39:831.e11-831.e18. [PMID: 34193378 DOI: 10.1016/j.urolonc.2021.05.022] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/25/2021] [Revised: 05/10/2021] [Accepted: 05/20/2021] [Indexed: 11/15/2022]
48
Whiting D, Bott SRJ. Current Diagnostics for Prostate Cancer. Prostate Cancer 2021. [DOI: 10.36255/exonpublications.prostatecancer.diagnostics.2021] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open
49
Environmental Factors-Induced Oxidative Stress: Hormonal and Molecular Pathway Disruptions in Hypogonadism and Erectile Dysfunction. Antioxidants (Basel) 2021;10:antiox10060837. [PMID: 34073826 PMCID: PMC8225220 DOI: 10.3390/antiox10060837] [Citation(s) in RCA: 23] [Impact Index Per Article: 7.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/02/2021] [Revised: 05/19/2021] [Accepted: 05/20/2021] [Indexed: 01/09/2023]  Open
50
Presti JC, Alexeeff S, Horton B, Prausnitz S, Avins AL. Prospective validation of the Kaiser Permanente prostate cancer risk calculator in a contemporary, racially diverse, referral population. Urol Oncol 2021;39:783.e11-783.e19. [PMID: 33962850 DOI: 10.1016/j.urolonc.2021.03.023] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/29/2020] [Revised: 02/26/2021] [Accepted: 03/28/2021] [Indexed: 10/21/2022]
PrevPage 1 of 4 1234Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA